• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Salvage surgery may improve survival in local recurrence of esophageal cancer

byMonica ParksandDavid Wang
September 20, 2014
in Chronic Disease, Gastroenterology, Oncology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The use of salvage surgery in locoregional recurrence of esophageal cancer following chemoradiotherapy demonstrated significantly increased survival compared to those who were unable to undergo salvage surgery.

Evidence Rating Level: 3 (Average)

Study Rundown: One of the most common approaches to the treatment of localized esophageal carcinoma is either chemoradiotherapy followed by surgery (aka trimodality therapy) or definitive chemotherapy (bimodality therapy, BMT). Previous studies have found that patients on BMT experience frequent local relapses, which may be treated with salvage surgical therapy. However, the current role of active surveillance for patients with BMT is unknown. The purpose of this study was to evaluate the timing and outcome of patients undergoing active surveillance following BMT for esophageal cancer.

At the conclusion of this retrospective cohort study of over 270 esophageal cancer patients, the authors found that local recurrence occurred in 23.2% (n=64) of patients, with the greatest risk of local recurrences occurring 2-3 years following BMT. Of the patients with local recurrence, 36% (n=23) of patients underwent salvage surgery therapy. Survival analysis demonstrated median overall survival of 58.6 months in patients that underwent salvage therapy, which was significantly increased from those who were unable to undergo salvage (9.5 months). This was the largest cohort of BMT patients to date and the findings provide strong support for the use of salvage therapy for patients with local recurrence following BMT and also support the role of vigilant surveillance for at least 24 months following definitive therapy. However, no cost analysis was performed, which may reduce the feasibility of a vigilant surveillance program.

Click to read the study in Journal of Clinical Oncology

Relevant Reading: Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies

In-Depth [retrospective cohort]: This retrospective cohort study included a total of 276 patients with esophageal cancer who were treated with definitive bimodality chemotherapy (BMT). The primary outcomes were local relapse and distant metastases, and the salvage treatment for patients with local relapse only. Median follow-up time was 54.3 months. At the conclusion of the study, of the 276 patients, 23.3% (n=64) were locoregional relapses only, 43.5% (n=120) distant metastasis without locoregional recurrence, and 33.3% (n=92) did not relapse. 91% and 98% of local recurrences occurred within 2 and 3 years following BMT, respectively. 36% (n=23) of patients with local recurrence only underwent salvage surgery with median overall survival of 58.6 months (95% CI, 28.8 to not reached) compared to 9.5 months (95% CI, 7.8 to 13.3) for those unable to undergo surgery.

RELATED REPORTS

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

#StudyGraphics: Gastric bypass surgery may reduce the risk of esophagogatric cancer in obese patients

#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: esophageal cancer
Previous Post

Long-term mortality benefit of BP lowering in type 2 diabetes [ADVANCE-ON trial]

Next Post

Afamelanotide plus UV-B phototherapy effective for vitiligo

RelatedReports

Nivolumab may be effective in platinum-resistant ovarian cancer
Gastroenterology

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

March 15, 2023
#StudyGraphics: Gastric bypass surgery may reduce the risk of esophagogatric cancer in obese patients
StudyGraphics

#StudyGraphics: Gastric bypass surgery may reduce the risk of esophagogatric cancer in obese patients

March 14, 2023
#VisualAbstract: Adjuvant ibandronate does not improve survival in  postmenopausal patients with ER⁺ breast cancer
StudyGraphics

#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma

October 5, 2022
#VisualAbstract: Concurrent use of tamoxifen with direct oral anticoagulants is not associated with an increased risk of hemorrhage
StudyGraphics

#VisualAbstract: FOLFOX in combination with nivolumab and trastuzumab improves survival in metastatic ERBB2⁺ esophagogastric adenocarcinoma

July 20, 2022
Next Post
Afamelanotide plus UV-B phototherapy effective for vitiligo

Afamelanotide plus UV-B phototherapy effective for vitiligo

Preterm birth associated with elevated plasma insulin levels

Hidradenitis suppurativa linked with metabolic syndrome

Statin use linked to increased risk of cataracts

Vitamin supplementation does not reduce the risk of cataract formation

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options